|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Batavia J, Yamany T, Molotkov A, Dan
H, Mansukhani M, Batourina E, Schneider K, Oyon D, Dunlop M, Wu XR,
et al: Bladder cancers arise from distinct urothelial
sub-populations. Nat Cell Biol. 16:982–991. 1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Youssef RF and Raj GV: Lymphadenectomy in
management of invasive bladder cancer. Int J Surg Oncol.
2011:7581892011.
|
|
5
|
Wu XR: Urothelial tumorigenesis: A tale of
divergent pathways. Nat Rev Cancer. 5:713–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hautmann RE, de Petriconi RC, Pfeiffer C
and Volkmer BG: Radical cystectomy for urothelial carcinoma of the
bladder without neoadjuvant or adjuvant therapy: Long-term results
in 1,100 patients. Eur Urol. 61:1039–1047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao Y: Opinion: Emerging mechanisms of
tumour lymphan-giogenesis and lymphatic metastasis. Nat Rev Cancer.
5:735–743. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karaman S and Detmar M: Mechanisms of
lymphatic metastasis. J Clin Invest. 124:922–928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar
|
|
11
|
Nakagawa S and Kageyama Y: Nuclear lncRNAs
as epigenetic regulators-beyond skepticism. Biochim Biophys Acta.
1839:215–222. 2014. View Article : Google Scholar
|
|
12
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ni W, Zhang Y, Zhan Z, Ye F, Liang Y,
Huang J, Chen K, Chen L and Ding Y: A novel lncRNA uc.134 represses
hepatocellular carcinoma progression by inhibiting CUL4A-mediated
ubiquiti-nation of LATS1. J Hematol Oncol. 10:912017. View Article : Google Scholar
|
|
14
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen DL, Lu YX, Zhang JX, Wei XL, Wang F,
Zeng ZL, Pan ZZ, Yuan YF, Wang FH, Pelicano H, et al: Long
non-coding RNA UICLM promotes colorectal cancer liver metastasis by
acting as a ceRNA for microRNA-215 to regulate ZEB2 expression.
Theranostics. 7:4836–4849. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu G, Ye Z, Zhao X and Ji Z: SP1-induced
up-regulation of lncRNA SNHG14 as a ceRNA promotes migration and
invasion of clear cell renal cell carcinoma by regulating N-WASP.
Am J Cancer Res. 7:2515–2525. 2017.
|
|
17
|
Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li
W, He A, Zhou L, Mei H, Wang F and Huang W: Increased expression of
ZEB1-AS1 correlates with higher histopathological grade and
promotes tumorigenesis in bladder cancer. Oncotarget.
8:24202–24212. 2017.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). method Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Gu P, Xie R, Han J, Liu H, Wang B,
Xie W, Xie W, Zhong G, Chen C, et al: Heterogeneous nuclear
ribonucleoprotein K is associated with poor prognosis and regulates
proliferation and apoptosis in bladder cancer. J Cell Mol Med.
21:1266–1279. 2017. View Article : Google Scholar :
|
|
21
|
Gong X, Du X, Xu Y and Zheng W: LINC00037
inhibits proliferation of renal cell carcinoma cells in an
epidermal growth factor receptor-dependent way. Cell Physiol
Biochem. 45:523–536. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu QC, Rui ZH, Guo ZL, Xie W, Shan S and
Ren T: LncRNA-DANCR contributes to lung adenocarcinoma progression
by sponging miR-496 to modulate mTOR expression. J Cell Mol Med.
22:1527–1537. 2018. View Article : Google Scholar
|
|
23
|
Moore AE, Chenette DM, Larkin LC and
Schneider RJ: Physiological networks and disease functions of
RNA-binding protein AUF1. Wiley Interdiscip Rev RNA. 5:549–564.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu TP, Wang YF, Xiong WL, Ma P, Wang WY,
Chen WM, Huang MD, Xia R, Wang R, Zhang EB, et al: E2F1 induces
TINCR transcriptional activity and accelerates gastric cancer
progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Cell Death Dis. 8:e28372017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su W, Xu M, Chen X, Chen N, Gong J, Nie L,
Li L, Li X, Zhang M and Zhou Q: Long noncoding RNA ZEB1-AS1
epigenetically regulates the expressions of ZEB1 and downstream
molecules in prostate cancer. Mol Cancer. 16:1422017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong WC, Han N, Wu N, Zhao KL, Han C,
Wang HX, Ping GF, Zheng PF, Feng H, Qin L and He P: Interplay
between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates
proliferation and migration of colorectal cancer cells. Am J Transl
Res. 10:605–617. 2018.PubMed/NCBI
|
|
28
|
Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin
CZ, Qu Q, Wang GH, He CJ and Zhou HH: A long noncoding RNA ZEB1-AS1
promotes tumorigenesis and predicts poor prognosis in glioma. Int J
Mol Sci. 17:E14312016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng R, Li N, Yang S, Liu L and Han S:
Long non-coding RNA ZEB1-AS1 promotes cell invasion and epithelial
to mesenchymal transition through inducing ZEB1 expression in
cervical cancer. Onco Targets Ther. 11:7245–7253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu C and Lin J: Long noncoding RNA-ZEB1
AS1 acts as an oncogene in osteosarcoma by epigenetically
activating ZEB1. Am J Transl Res. 8:4095–4105. 2016.
|
|
31
|
Qu R, Chen X and Zhang C: LncRNA
ZEB1-AS1/miR-409-3p/ZEB1 feedback loop is involved in the
progression of non-small cell lung cancer. Biochem Biophys Res
Commun. 507:450–456. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi YJ, Yoon JH and Chang JH: Crystal
structure of the N-Terminal RNA recognition motif of mRNA decay
regulator AUF1. Biomed Res Int. 2016:32861912016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li S, Zhang HY, Du ZX, Li C, An MX, Zong
ZH, Liu BQ and Wang HQ: Induction of epithelial-mesenchymal
transition (EMT) by Beclin 1 knockdown via posttranscriptional
upregulation of ZEB1 in thyroid cancer cells. Oncotarget.
7:70364–70377. 2016.PubMed/NCBI
|
